JOHN VIERLING to Muromonab-CD3
This is a "connection" page, showing publications JOHN VIERLING has written about Muromonab-CD3.
Connection Strength
0.052
-
The clinical and immunologic impact of using interferon and ribavirin in the immunosuppressed host. Liver Transpl. 2003 Nov; 9(11):S79-89.
Score: 0.052
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.